E-DRUG Archives (by thread)

  • Re: E-DRUG: Flunitrazepam (Rohypnol (R) ) Abuse Potential, David Woods
  • E-DRUG: Re: Flunitrazepam (Rohypnol (R) ) Abuse Potential, Min Chen 301-827-3169 FAX 301-827-5190
  • E-DRUG: International Herald Tribune, Ellen 't Hoen
  • E-DRUG: WHO Press Release on Drug Donations to Albania, Mark Raijmakers, Wemos
  • E-DRUG: Problem suppliers (cont'd), hamis
  • E-DRUG: Free access to eMaLAM, Peter Mansfield
  • E-DRUG: Flunitrazepam (Rohypnol (R)) Abuse Potential, Dr.L.Offerhaus
  • E-DRUG: Drug Donations to Kosovo, Richard . Laing
  • E-DRUG: The future of pharmaceutical industry in Asean, adpc
  • E-DRUG: Revolving Fund Bulk Purchase Schemes (BPS) for Pharmaceuticals, Mr M.C.E. Bailey
  • E-DRUG: Bulk Purchasing Schemes, Mr M.C.E. Bailey
  • E-DRUG: RE:Revolving Fund Bulk Purchase Schemes (BPS) for Pharmaceuticals, Dumoulin
  • E-DRUG: Media attention on drug donations to Kosovo, Mark Raijmakers, Wemos
  • E-DRUG: Drug Donation, Paul
  • E-DRUG: Bulk Purchase Schemes & Pooled Usage, Mr M.C.E. Bailey
  • E-DRUG: HIV Drug Donation, Defty, Douglas
  • E-DRUG: Drug donations, Dr.L.Offerhaus
  • E-DRUG: Table of contents of Prescrire International, August 1999, Prescrire / International
  • E-DRUG: article on the BMJ on donations, Mark Raijmakers, Wemos
  • E-DRUG: Bulk Purchase Schemes (BPS): Summary, Mr M.C.E. Bailey
  • E-DRUG: Alert - Thimerosal in Vaccines, srahmad
  • E-DRUG: ABC Transcript -- we are better off if African patients die, James Love
  • E-DRUG: Brundtland and HAI responses on drug industry sponsorship, Lisa Hayes
  • E-DRUG: NIMESULIDE FOR CHILDREN, Accion Internacional Para la Salud
  • E-DRUG: WHO Partnerships and Sponsorship, Christophe Kopp
  • E-DRUG: Dissertation about expired drugs, Naomi Adams
  • E-DRUG: RE: PROBLEM MANUFACTURERS/DRUG AUTHORITY?, Andrew Walubo
  • R: E-DRUG: NIMESULIDE FOR CHILDREN, Antonio Addis
  • E-DRUG: Hymenolepis nana infection, Rogerio Hoefler
  • E-DRUG: E-Drug : Nimesulide, RAJ VAIDYA
  • Re: E-DRUG: Nimesulide, Dr.L.Offerhaus
  • E-DRUG: Re:flunitrazepam, Beverley Snell
  • E-DRUG: Last posting about Nimesulide, Blaine P. Carmichael, PA-C
  • E-DRUG: E-Drug:Nimesulide, Dr.L.Offerhaus
  • E-DRUG: siting of community pharmacies, Mrs Rachel Fitzpatrick
  • E-DRUG: nevirapine for mother to child HIV prevention, NIAID/NIH pressrelease
  • E-DRUG: Curious abortion device from Norway????, RAJ VAIDYA
  • E-DRUG: IHT Letter from Ellen t'Hoen, ethoen
  • E-DRUG: ABC: Affordable medicine for Africans dangerous?, Robert Weissman
  • E-DRUG: In Defense of Al Gore- Just This Once, James Love
  • E-DRUG: Curious abortion device from Norway???? More information, bremerk
  • E-DRUG: Re: abortion device from Norway, Kirsten . Myhr . myhr
  • E-DRUG: ICH and developing countries, Wilbert Bannenberg
  • E-DRUG: summary of my dissertation, Naomi Adams
  • E-DRUG: USA-SA deal on drug patents at hand?, James Love
  • E-DRUG: Nemisulide Nepalese DRA's reason for giving temporary registration, dda
  • Re: E-DRUG:ICH, Catherine Hodgkin
  • E-DRUG: South African CL and PI clause, James Love
  • E-DRUG: Expiry dates/dating of Pharmaceuticals, sesaym
  • E-DRUG: MSF AIDS Statement to US Congressional Committee, Daniel BERMAN
  • E-DRUG: USA Trade Representative and New Zealand, James Love
  • Re: E-DRUG: Investigation of Amgen suppression of EPO invention, Randy Trinkle
  • E-DRUG: Re- E-drug: ICH and developing countries, Patrice Trouiller
  • E-DRUG: prescribing on the internet, E-drug
  • E-DRUG: Kansas sues internet medicine suppliers, E-drug
  • E-DRUG: WHO/EDM Technical Briefing Seminar, Nov 99., hogerzeilh
  • E-DRUG: dur/due resources, Randy Trinkle
  • E-DRUG: Simple, affordable prevention of vertical HIV transmission, TAvSchoen
  • E-DRUG: 1st ASIAN COURSE ON PROBLEM-BASED PHARMACOTHERAPY SECOND ANNOUNCEMENT, David Henry
  • RE: E-DRUG: dur/due resources Australia, Libby Roughead
  • E-DRUG: USTR on compulsory licensing or parallel import, James Love
  • E-DRUG: Wanted -Chief, Poison Control Center,Oman, srahmad
  • E-DRUG: Workshop on Drug Development announcement, Patrice Trouiller
  • RE: E-DRUG: Simple, affordable prevention of vertical HIV, Peter Lurie
  • E-DRUG: Request for information, Aoife Collins
  • Re: E-DRUG: Kansas sues internet medicine suppliers Response, Scondras
  • Re: E-DRUG: NEVIRAPINE OR PLACEBO?, Andrew Walubo
  • E-DRUG: Risks for patients in clinical trials, Charles Medawar
  • E-DRUG: Alert-Renal failure associated with Chinese herbal med, srahmad
  • E-DRUG: Good or bad clinical practice?, E-drug
  • E-DRUG: Access to essential drugs conference, Daniel BERMAN
  • E-DRUG: Psychiatric drug prices, MANOJ
  • E-DRUG: Liliaceae experts?, ruzangi peter
  • E-DRUG: 2nd P-drug workshop in Japan, Kiichiro TSUTANI
  • E-DRUG: off-label use and free (commercial) speech?, Marita van Rooyen
  • E-DRUG: Watch out for the REPLY button!, E-drug moderator
  • E-DRUG: Clinical trial publication requirement abolished in Japan, Chieko Kurihara

  • Mail converted by MHonArc 2.6.8